CD274 and leukemia: In this study we tested the hypothesis that integrating specific antibody recognition sites for PD-L1 into a CAR will endow T cells with both specificity against PD-L1-expressing leukemia cells and resistance to PD-1/PD-L1-mediated immunosuppression.